"Visual diet," or the images that women see, may be just as critical to their weight preferences as associating certain body types with success, according to research published Nov. 7 in the open access journal PLOS ONE by Lynda Boothroyd at Durham University with colleagues from Newcastle University, United Kingdom.
Preferences for a particular body size may result from exposure to images of other women, or from learning that a certain body type is associated with aspirational goals such as high status or better health. To test which of these two influences may be more important in directing women's preferences, the researchers showed women a series of photographs of women of varying weights in high-end clothing, as well as eating-disordered patients in grey leotards. The participants' preferences for particular body types were evaluated before and after they saw different combinations of these pictures.
The results showed that viewing one type of figure, either smaller or larger, increased women's preference for that body type, regardless of whether they were depicted as aspirational or not. To a lesser extent, the researchers also found that exposure to aspirational images of overweight women could induce a preference for larger body types, even in the presence of lower-weight figures in the non-aspirational category. According to the authors, these results show significant support for the effect of a 'visual' diet.
Lead author Boothroyd says, "This really gives us some food for thought about the power of exposure to super-slim bodies. There is evidence that being constantly surrounded through the media by celebrities and models who are very thin contributes to girls and women having an unhealthy attitude to their bodies. Furthermore, it seems that even so-called 'cautionary' images against anorexia might still increase our liking for thinner bodies, such as those featuring the late French model Isabelle Caro, which is a sobering thought."
Public Library of Science: http://www.plos.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Doctors have used perfect replicas of childrens' hearts to uncover and repair hidden defects
An experiment testing people’s altruism in the face of electric shocks is clear on one thing: we are drawn to these little blasts
Researchers gear up tests in West Africa to see whether blood from Ebola survivors can help people who are sick with the disease. This is part of a broader effort to test therapies in West Africa.
The virus's foray into Europe coincides with peak production of Christmas turkeys, the poultry species most vulnerable to bird flu
A novel kind of nanoparticle could lead to more effective cancer treatments.Patients and doctors often don’t know if surgery to remove cancerous tissue was successful until scans are performed months later. A new kind of nanoparticle could show patients if they’re in the clear much earlier.
One challenge in evaluating the effectiveness of different medical procedures, is that patients behave differently after different procedures. Is this true for patients getting heart surgery?
It is only in the aftermath of treatment that survivors discern that their adrenalin alone wont fuel the rest of their recovery. For many, surviving cancer is followed by even more hardship
Just down the road from Facebook and Google, Dr. Phil Wagner runs a laboratory dedicated to optimizing the performance of some of the world's top athletes. At Sparta Performance Science in Menlo Park, California, Wagner and his team bring the spirit of Silicon Valley to bear on the athletic world, helping athletes find the tiny advantages that add to championships. Join us for a trip inside the lab to see where sports meets science.
Pieter Cohen, an internist in Massachusetts, got interested in dietary supplements several years ago, when some of his …
The risk of overdiagnosis and false positives means the UK may be barking up the wrong tree in trialling a wider target age range for breast screening